Teruo Sekimoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Teruo Sekimoto has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Aloke Virmani Finn
CVPath Institute, Gaithersburg, MD, USA
7 shared publications - Renu Virmani
CVPath Institute, Gaithersburg, MD
7 shared publications - Rika Kawakami
CVPath Institute, Inc, Gaithersburg, USA
7 shared publications - Atsushi Sakamoto
CVPath Institute, Inc, Gaithersburg, USA
5 shared publications - Tatsuya Shiraki
CVPath Institute Inc. Gaithersburg Maryland USA
4 shared publications - Alyssa Grogan
CVPath Institute, Inc, Gaithersburg, MD (T.T., R.K., D.W., J.A., A.S., H.J., K.K., T.K., T. Shiraki, T. Sekimoto, T.N., K.F., T.H., Y.A., K.M.D., A.G., R.V., A.V.F.).
3 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Diagnostic Performance of a Dual Sensor System in Assessment of Coronary Calcification: An Ex Vivo Cadaveric Study
Background: Accurate assessment of coronary calcification informs procedural planning in percutaneous coronary intervention (PCI), yet neither optical frequency domain imaging (OFDI) nor intravascular ultrasound (IVUS) alone provides comprehensive diagnostic information. The dual sensor system (DSS) was developed to integrate and complement both imaging modalities. Aims: To determine the diagnostic value of DSS for detecting and characterizing calcification compared with either modality alone. Methods: Twenty coronary arteries from 17 cadaver hearts underwent DSS pullbacks. Eighty‐seven histological sections and their co‐registered DSS images were analyzed, with histology serving as the reference standard. Four cardiologists blinded to histology independently assessed calcification using OFDI alone, IVUS alone, and DSS. OFDI signal attenuation and IVUS reverberation artifacts were examined as potential indicators of maximum calcification thickness. Results: DSS demonstrated the highest sensitivity (DSS 98.0%; OFDI 85.5%, p < 0.001; IVUS 94.4%, p = 0.019) and accuracy (DSS, 97.7%; OFDI, 86.5%, p < 0.001; IVUS, 92.8%, p = 0.004) for detecting calcification. Inter‐observer agreement was also highest in DSS ( κ : DSS, 0.82; OFDI, 0.53; IVUS, 0.53). In subgroup analysis, sensitivity was significantly higher in DSS for sections with calcification arc < 180° (DSS, 98.6%; OFDI, 83.8%; IVUS, 94.0%), but not for those with ≥ 180°. Maximum calcification thickness was greater in calcifications only with OFDI attenuation than in those without (1423.8 [988.8−1994.1] vs. 686.4 [552.8−906.3] µm, p < 0.001). Conclusions: DSS provides accurate and consistent detection of coronary calcification and may help stratify calcification by thickness. Future studies should assess whether these advantages translate into clinical benefits.
- 30 October 2026
- Published by Wiley in Catheterization and Cardiovascular Interventions
Open AccessDiagnostic Performance of a Dual Sensor System in Assessment of Coronary Calcification: An Ex Vivo Cadaveric Study
Background: Accurate assessment of coronary calcification informs procedural planning in percutaneous coronary intervention (PCI), yet neither optical frequency domain imaging (OFDI) nor intravascular ultrasound (IVUS) alone provides comprehensive diagnostic information. The dual sensor system (DSS) was developed to integrate and complement both imaging modalities. Aims: To determine the diagnostic value of DSS for detecting and characterizing calcification compared with either modality alone. Methods: Twenty coronary arteries from 17 cadaver hearts underwent DSS pullbacks. Eighty‐seven histological sections and their co‐registered DSS images were analyzed, with histology serving as the reference standard. Four cardiologists blinded to histology independently assessed calcification using OFDI alone, IVUS alone, and DSS. OFDI signal attenuation and IVUS reverberation artifacts were examined as potential indicators of maximum calcification thickness. Results: DSS demonstrated the highest sensitivity (DSS 98.0%; OFDI 85.5%, p < 0.001; IVUS 94.4%, p = 0.019) and accuracy (DSS, 97.7%; OFDI, 86.5%, p < 0.001; IVUS, 92.8%, p = 0.004) for detecting calcification. Inter‐observer agreement was also highest in DSS ( κ : DSS, 0.82; OFDI, 0.53; IVUS, 0.53). In subgroup analysis, sensitivity was significantly higher in DSS for sections with calcification arc < 180° (DSS, 98.6%; OFDI, 83.8%; IVUS, 94.0%), but not for those with ≥ 180°. Maximum calcification thickness was greater in calcifications only with OFDI attenuation than in those without (1423.8 [988.8−1994.1] vs. 686.4 [552.8−906.3] µm, p < 0.001). Conclusions: DSS provides accurate and consistent detection of coronary calcification and may help stratify calcification by thickness. Future studies should assess whether these advantages translate into clinical benefits.
- 6 October 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (14) , 1309-1321
Pathology of Genetic Variants in Spontaneous Coronary Artery Dissection
BACKGROUND: Spontaneous coronary artery dissection (SCAD) is characterized by a separation of the coronary artery wall, causing myocardial infarction and sudden death. This study is one of the first to clarify the impact of pathological genetic variants in candidate SCAD-related genes on the histopathological and morphological properties of human SCAD lesions. METHODS: A total of 28 SCAD cases were selected from the CVPath Autopsy Registry. Histological differences in collagen and smooth muscle cells were compared among 3 groups: culprit SCAD (C-SCAD), defined as the coronary segment containing a dissection in cases with SCAD; nonculprit SCAD, defined as unaffected coronary segments (ie, healthy arteries) in cases with SCAD; and non-SCAD controls. Whole-exome sequencing was performed, and the identified variants were filtered to isolate pathogenic or likely pathogenic variants. Protein expression corresponding to the identified variants was assessed by immunostaining. RESULTS: Collagen content was significantly reduced in C-SCAD lesions compared with controls, and immunohistochemical staining for smoothelin was reduced in the media of C-SCAD lesions compared with controls, whereas there were no significant differences between C-SCAD and nonculprit SCAD. Further, the nuclear height/width ratio of smooth muscle cells was increased, suggesting smooth muscle cell phenotypic modulation. In whole-exome sequencing analysis, pathogenic or likely pathogenic variants were detected in 25% of cases, which showed a higher frequency of multivessel dissection. In SCAD cases with pathogenic or likely pathogenic variants in COL3A1 (collagen type III alpha 1), FBN1 (fibrillin-1), or FLNA (filamin A), the expression of the corresponding protein was reduced in the media. CONCLUSIONS: Reduced medial collagen and smooth muscle cell phenotypic modulation may be possible predisposing conditions for SCAD, regardless of the presence of pathogenic or likely pathogenic variants. The presence of pathogenic variants in extracellular matrix–related genes may further compromise arterial wall medial integrity, contributing to more severe disease. These findings provide novel pathological and genetic insights into the pathogenesis of SCAD and may inform future diagnostic and therapeutic strategies.
- 6 October 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (14) , 1309-1321
Pathology of Genetic Variants in Spontaneous Coronary Artery Dissection
BACKGROUND: Spontaneous coronary artery dissection (SCAD) is characterized by a separation of the coronary artery wall, causing myocardial infarction and sudden death. This study is one of the first to clarify the impact of pathological genetic variants in candidate SCAD-related genes on the histopathological and morphological properties of human SCAD lesions. METHODS: A total of 28 SCAD cases were selected from the CVPath Autopsy Registry. Histological differences in collagen and smooth muscle cells were compared among 3 groups: culprit SCAD (C-SCAD), defined as the coronary segment containing a dissection in cases with SCAD; nonculprit SCAD, defined as unaffected coronary segments (ie, healthy arteries) in cases with SCAD; and non-SCAD controls. Whole-exome sequencing was performed, and the identified variants were filtered to isolate pathogenic or likely pathogenic variants. Protein expression corresponding to the identified variants was assessed by immunostaining. RESULTS: Collagen content was significantly reduced in C-SCAD lesions compared with controls, and immunohistochemical staining for smoothelin was reduced in the media of C-SCAD lesions compared with controls, whereas there were no significant differences between C-SCAD and nonculprit SCAD. Further, the nuclear height/width ratio of smooth muscle cells was increased, suggesting smooth muscle cell phenotypic modulation. In whole-exome sequencing analysis, pathogenic or likely pathogenic variants were detected in 25% of cases, which showed a higher frequency of multivessel dissection. In SCAD cases with pathogenic or likely pathogenic variants in COL3A1 (collagen type III alpha 1), FBN1 (fibrillin-1), or FLNA (filamin A), the expression of the corresponding protein was reduced in the media. CONCLUSIONS: Reduced medial collagen and smooth muscle cell phenotypic modulation may be possible predisposing conditions for SCAD, regardless of the presence of pathogenic or likely pathogenic variants. The presence of pathogenic variants in extracellular matrix–related genes may further compromise arterial wall medial integrity, contributing to more severe disease. These findings provide novel pathological and genetic insights into the pathogenesis of SCAD and may inform future diagnostic and therapeutic strategies.
- Open Access
- 30 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (10)
Early structural valve deterioration after TAVR and potential association with long-term corticosteroid therapy: a case report
Background: Early structural valve deterioration (SVD) after transcatheter aortic valve replacement (TAVR) for aortic stenosis is uncommon, particularly within 5 years post-implantation. The impact of long-term corticosteroid therapy on transcatheter bioprosthetic valve durability remains poorly understood. Case summary: An 80-year-old woman presented with severe calcific SVD 4.5 years after undergoing TAVR with a balloon-expandable transcatheter aortic valve, requiring surgical explantation and aortic valve replacement. She had received long-term corticosteroid therapy for bullous pemphigoid for over 9 years, complicated by steroid-induced diabetes mellitus and progressive chronic kidney disease. While post-procedural echocardiography initially confirmed favourable valve function (peak velocity 2.5 m/s, mean gradient 14.2 mmHg), follow-up echocardiography revealed Stage3 (severe) haemodynamic SVD, with a markedly reduced effective orifice area of 0.48 cm2 and an elevated peak/mean gradient of 139.2/80.1 mmHg (peak velocity 5.9 m/s). Computed tomography revealed marked leaflet calcification without evidence of hypoattenuated leaflet thickening or thrombosis. Pathological examination of the explanted valve confirmed advanced intrinsic and extrinsic calcific degeneration without active inflammation. Although moderate patient–prosthesis mismatch was present, these findings suggest that the patient’s systemic pro-calcific metabolic environment—driven by prolonged corticosteroid therapy and its associated metabolic comorbidities—might have played a key role in accelerating SVD. Discussion: While hypothesis-generating, our findings suggest that long-term corticosteroid therapy and associated metabolic disorders might contribute to early transcatheter valve deterioration. Careful echocardiographic follow-up should be considered in post-TAVR patients with complex metabolic risk profiles.
- 30 September 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 10 (10)
Open AccessEarly structural valve deterioration after TAVR and potential association with long-term corticosteroid therapy: a case report
Background: Early structural valve deterioration (SVD) after transcatheter aortic valve replacement (TAVR) for aortic stenosis is uncommon, particularly within 5 years post-implantation. The impact of long-term corticosteroid therapy on transcatheter bioprosthetic valve durability remains poorly understood. Case summary: An 80-year-old woman presented with severe calcific SVD 4.5 years after undergoing TAVR with a balloon-expandable transcatheter aortic valve, requiring surgical explantation and aortic valve replacement. She had received long-term corticosteroid therapy for bullous pemphigoid for over 9 years, complicated by steroid-induced diabetes mellitus and progressive chronic kidney disease. While post-procedural echocardiography initially confirmed favourable valve function (peak velocity 2.5 m/s, mean gradient 14.2 mmHg), follow-up echocardiography revealed Stage3 (severe) haemodynamic SVD, with a markedly reduced effective orifice area of 0.48 cm2 and an elevated peak/mean gradient of 139.2/80.1 mmHg (peak velocity 5.9 m/s). Computed tomography revealed marked leaflet calcification without evidence of hypoattenuated leaflet thickening or thrombosis. Pathological examination of the explanted valve confirmed advanced intrinsic and extrinsic calcific degeneration without active inflammation. Although moderate patient–prosthesis mismatch was present, these findings suggest that the patient’s systemic pro-calcific metabolic environment—driven by prolonged corticosteroid therapy and its associated metabolic comorbidities—might have played a key role in accelerating SVD. Discussion: While hypothesis-generating, our findings suggest that long-term corticosteroid therapy and associated metabolic disorders might contribute to early transcatheter valve deterioration. Careful echocardiographic follow-up should be considered in post-TAVR patients with complex metabolic risk profiles.
- 13 June 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (8) , 1624-1635
Association of small dense LDL cholesterol and inflammation with plaque rupture in acute coronary syndrome: An OCT study
- 13 June 2026
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 20 (8) , 1624-1635
Association of small dense LDL cholesterol and inflammation with plaque rupture in acute coronary syndrome: An OCT study
- 1 February 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (2)
Lipid-Related Polygenic Risk Score and Its Association With Plaque Rupture Versus Erosion
BACKGROUND: Distinct plaque morphologies underlie the major causes of acute coronary syndrome and sudden cardiac death. We used polygenic risk scores (PRSs) for hypercholesterolemia and hypertriglyceridemia, 2 major risk factors for coronary artery disease (CAD), to evaluate the relative contributions of these risk factors to specific plaque morphologies, specifically plaque rupture and erosion. METHODS: DNA was extracted from formalin-fixed paraffin-embedded tissues and genotyped for 954 subjects from our sudden death autopsy registry, with cause of death determined by autopsy. LDL (low-density lipoprotein)–specific and triglyceride-specific PRSs were constructed based on the Global Lipids Genetics Consortium genome-wide association study results, excluding variants associated with both traits ( P P =0.017), ≥75% lumen narrowing (OR, 1.33 [95% CI, 1.13–1.57]; P P =0.016), and CAD-related death (OR, 1.31 [95% CI, 1.13–1.52]; P P =0.020) and showed a trend toward association with plaque rupture (OR, 1.15 [95% CI, 0.98–1.35]; P =0.091). No association was observed between LDL-/triglyceride-specific PRS and plaque erosion. CONCLUSIONS: This is the first study to associate lipid PRSs with specific plaque morphologies, revealing distinct pathogenic mechanisms underlying plaque rupture and erosion. Early genetic risk stratification and subsequent lipid-lowering interventions may provide substantial clinical benefits in mitigating cardiovascular risk, particularly in relation to plaque rupture. Our findings raise questions about the effectiveness of such strategies in preventing plaque erosion, suggesting the need for further investigation into its underlying pathogenesis.
- 1 February 2026
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 46 (2)
Lipid-Related Polygenic Risk Score and Its Association With Plaque Rupture Versus Erosion
BACKGROUND: Distinct plaque morphologies underlie the major causes of acute coronary syndrome and sudden cardiac death. We used polygenic risk scores (PRSs) for hypercholesterolemia and hypertriglyceridemia, 2 major risk factors for coronary artery disease (CAD), to evaluate the relative contributions of these risk factors to specific plaque morphologies, specifically plaque rupture and erosion. METHODS: DNA was extracted from formalin-fixed paraffin-embedded tissues and genotyped for 954 subjects from our sudden death autopsy registry, with cause of death determined by autopsy. LDL (low-density lipoprotein)–specific and triglyceride-specific PRSs were constructed based on the Global Lipids Genetics Consortium genome-wide association study results, excluding variants associated with both traits ( P P =0.017), ≥75% lumen narrowing (OR, 1.33 [95% CI, 1.13–1.57]; P P =0.016), and CAD-related death (OR, 1.31 [95% CI, 1.13–1.52]; P P =0.020) and showed a trend toward association with plaque rupture (OR, 1.15 [95% CI, 0.98–1.35]; P =0.091). No association was observed between LDL-/triglyceride-specific PRS and plaque erosion. CONCLUSIONS: This is the first study to associate lipid PRSs with specific plaque morphologies, revealing distinct pathogenic mechanisms underlying plaque rupture and erosion. Early genetic risk stratification and subsequent lipid-lowering interventions may provide substantial clinical benefits in mitigating cardiovascular risk, particularly in relation to plaque rupture. Our findings raise questions about the effectiveness of such strategies in preventing plaque erosion, suggesting the need for further investigation into its underlying pathogenesis.
- Open Access
- 25 June 2025
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 27 (1) , 1
Correction to: Biomarkers Differentiating Plaque Erosion from Stable Plaque
- 25 June 2025
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 27 (1) , 1
Open AccessCorrection to: Biomarkers Differentiating Plaque Erosion from Stable Plaque
- 24 May 2025
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 27 (1) , 1-9
Biomarkers Differentiating Plaque Erosion from Stable Plaque
Purpose of Review Plaque erosion is the second most frequent cause of acute coronary syndrome, yet the biological processes and biomarkers associated with erosion remain incompletely understood. This review aims to examine the current understanding of plaque erosion, with a focus on identifying potential biomarkers. Recent Findings Recent studies have identified distinct pathophysiological characteristics associated with plaque erosion, including variations in inflammatory response and immune cell infiltration within the culprit lesions and thrombi. Additionally, differences in the expression patterns of specific molecules have been noted, suggesting unique underlying mechanisms that contribute to plaque erosion. Summary Understanding the differential expression and role of immune cells and biomarkers in erosion may be crucial for developing targeted therapies. The identification of biomarkers may help in the early detection and treatment of erosion-prone plaques, potentially reducing the incidence of acute coronary events.
- 24 May 2025
- Published by Springer Nature in Current Atherosclerosis Reports
- Vol. 27 (1) , 1-9
Biomarkers Differentiating Plaque Erosion from Stable Plaque
Purpose of Review Plaque erosion is the second most frequent cause of acute coronary syndrome, yet the biological processes and biomarkers associated with erosion remain incompletely understood. This review aims to examine the current understanding of plaque erosion, with a focus on identifying potential biomarkers. Recent Findings Recent studies have identified distinct pathophysiological characteristics associated with plaque erosion, including variations in inflammatory response and immune cell infiltration within the culprit lesions and thrombi. Additionally, differences in the expression patterns of specific molecules have been noted, suggesting unique underlying mechanisms that contribute to plaque erosion. Summary Understanding the differential expression and role of immune cells and biomarkers in erosion may be crucial for developing targeted therapies. The identification of biomarkers may help in the early detection and treatment of erosion-prone plaques, potentially reducing the incidence of acute coronary events.
- Open Access
- 1 February 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (2) , e014523
Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening
BACKGROUND: Hypoattenuated leaflet thickening (HALT) is believed to reflect leaflet thrombosis; however, no systematic histological examination of HALT has ever been performed. The aim of this study was to evaluate histological findings of explanted self-expanding transcatheter aortic bioprosthetic valves from clinical trials and to compare microCT findings of suspected HALT with histology findings of valve thrombosis and its characterization over time. METHODS: A total of 123 self-expanding transcatheter aortic valves were collected through autopsy (n=89) or surgical explant (n=34) from 11 CoreValve/Evolut clinical trials. Histological findings in transcatheter aortic valve leaflets were evaluated. MicroCT imaging was used to evaluate HALT in histology. Cases with infective endocarditis (10/123) or transcatheter aortic valve-in-surgical aortic valve procedures (3/123) were excluded. RESULTS: A total of 110 cases were divided into 3 groups based on implant duration: 365 days (n=33). Thrombus and inflammation scores were consistent across groups, while scores for pannus, calcification, and structural change increased over time. The analysis of leaflet thickening by histology was performed on 320 leaflets and any degree of leaflet thickening was observed in 46.5% (149/320) of leaflets. Histologically, leaflet thickening was confirmed as an acute, organizing, and organized thrombus (ie, pannus). In the 30 days. The types of thrombi could not be differentiated by microCT imaging. CONCLUSIONS: HALT represents the presence of a thrombus and its progression. Our data suggest that treatment of HALT would likely be most effective in the early stages before the thrombus becomes organized and emphasizes the need for early detection.
- 1 February 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 18 (2) , e014523
Open AccessPathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening
BACKGROUND: Hypoattenuated leaflet thickening (HALT) is believed to reflect leaflet thrombosis; however, no systematic histological examination of HALT has ever been performed. The aim of this study was to evaluate histological findings of explanted self-expanding transcatheter aortic bioprosthetic valves from clinical trials and to compare microCT findings of suspected HALT with histology findings of valve thrombosis and its characterization over time. METHODS: A total of 123 self-expanding transcatheter aortic valves were collected through autopsy (n=89) or surgical explant (n=34) from 11 CoreValve/Evolut clinical trials. Histological findings in transcatheter aortic valve leaflets were evaluated. MicroCT imaging was used to evaluate HALT in histology. Cases with infective endocarditis (10/123) or transcatheter aortic valve-in-surgical aortic valve procedures (3/123) were excluded. RESULTS: A total of 110 cases were divided into 3 groups based on implant duration: 365 days (n=33). Thrombus and inflammation scores were consistent across groups, while scores for pannus, calcification, and structural change increased over time. The analysis of leaflet thickening by histology was performed on 320 leaflets and any degree of leaflet thickening was observed in 46.5% (149/320) of leaflets. Histologically, leaflet thickening was confirmed as an acute, organizing, and organized thrombus (ie, pannus). In the 30 days. The types of thrombi could not be differentiated by microCT imaging. CONCLUSIONS: HALT represents the presence of a thrombus and its progression. Our data suggest that treatment of HALT would likely be most effective in the early stages before the thrombus becomes organized and emphasizes the need for early detection.
- 5 July 2024
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 135 (2) , e4-e23
CD163 + Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma
BACKGROUND: Cell phenotype switching is increasingly being recognized in atherosclerosis. However, our understanding of the exact stimuli for such cellular transformations and their significance for human atherosclerosis is still evolving. Intraplaque hemorrhage is thought to be a major contributor to plaque progression in part by stimulating the influx of CD163 + macrophages. Here, we explored the hypothesis that CD163 + macrophages cause plaque progression through the induction of proapoptotic endothelial-to-mesenchymal transition (EndMT) within the fibrous cap. METHODS: Human coronary artery sections from CVPath’s autopsy registry were selected for pathological analysis. Athero-prone ApoE −/− and ApoE −/− /CD163 −/− mice were used for in vivo studies. Human peripheral blood mononuclear cell–induced macrophages and human aortic endothelial cells were used for in vitro experiments. RESULTS: In 107 lesions with acute coronary plaque rupture, 55% had pathological evidence of intraplaque hemorrhage in nonculprit vessels/lesions. Thinner fibrous cap, greater CD163 + macrophage accumulation, and a larger number of CD31/FSP-1 (fibroblast specific protein-1) double-positive cells and TUNEL (terminal deoxynucleotidyl transferase-dUTP nick end labeling) positive cells in the fibrous cap were observed in nonculprit intraplaque hemorrhage lesions, as well as in culprit rupture sections versus nonculprit fibroatheroma sections. Human aortic endothelial cells cultured with supernatants from hemoglobin/haptoglobin-exposed macrophages showed that increased mesenchymal marker proteins (transgelin and FSP-1) while endothelial markers (VE-cadherin and CD31) were reduced, suggesting EndMT induction. Activation of NF-κB (nuclear factor kappa β) signaling by proinflammatory cytokines released from CD163 + macrophages directly regulated the expression of Snail, a critical transcription factor during EndMT induction. Western blot analysis for cleaved caspase-3 and microarray analysis of human aortic endothelial cells indicated that apoptosis was stimulated during CD163 + macrophage–induced EndMT. Additionally, CD163 deletion in athero-prone mice suggested that CD163 is required for EndMT and plaque progression. Using single-cell RNA sequencing from human carotid endarterectomy lesions, a population of EndMT was detected, which demonstrated significant upregulation of apoptosis-related genes. CONCLUSIONS: CD163 + macrophages provoke EndMT, which may promote plaque progression through fibrous cap thinning.
- 5 July 2024
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 135 (2) , e4-e23
CD163 + Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma
BACKGROUND: Cell phenotype switching is increasingly being recognized in atherosclerosis. However, our understanding of the exact stimuli for such cellular transformations and their significance for human atherosclerosis is still evolving. Intraplaque hemorrhage is thought to be a major contributor to plaque progression in part by stimulating the influx of CD163 + macrophages. Here, we explored the hypothesis that CD163 + macrophages cause plaque progression through the induction of proapoptotic endothelial-to-mesenchymal transition (EndMT) within the fibrous cap. METHODS: Human coronary artery sections from CVPath’s autopsy registry were selected for pathological analysis. Athero-prone ApoE −/− and ApoE −/− /CD163 −/− mice were used for in vivo studies. Human peripheral blood mononuclear cell–induced macrophages and human aortic endothelial cells were used for in vitro experiments. RESULTS: In 107 lesions with acute coronary plaque rupture, 55% had pathological evidence of intraplaque hemorrhage in nonculprit vessels/lesions. Thinner fibrous cap, greater CD163 + macrophage accumulation, and a larger number of CD31/FSP-1 (fibroblast specific protein-1) double-positive cells and TUNEL (terminal deoxynucleotidyl transferase-dUTP nick end labeling) positive cells in the fibrous cap were observed in nonculprit intraplaque hemorrhage lesions, as well as in culprit rupture sections versus nonculprit fibroatheroma sections. Human aortic endothelial cells cultured with supernatants from hemoglobin/haptoglobin-exposed macrophages showed that increased mesenchymal marker proteins (transgelin and FSP-1) while endothelial markers (VE-cadherin and CD31) were reduced, suggesting EndMT induction. Activation of NF-κB (nuclear factor kappa β) signaling by proinflammatory cytokines released from CD163 + macrophages directly regulated the expression of Snail, a critical transcription factor during EndMT induction. Western blot analysis for cleaved caspase-3 and microarray analysis of human aortic endothelial cells indicated that apoptosis was stimulated during CD163 + macrophage–induced EndMT. Additionally, CD163 deletion in athero-prone mice suggested that CD163 is required for EndMT and plaque progression. Using single-cell RNA sequencing from human carotid endarterectomy lesions, a population of EndMT was detected, which demonstrated significant upregulation of apoptosis-related genes. CONCLUSIONS: CD163 + macrophages provoke EndMT, which may promote plaque progression through fibrous cap thinning.
- Open Access
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Clinical features and lipid profiles of plaque erosion over lipid rich plaque versus fibrous plaque
Backgrounds and aims: Plaque erosion (PE) which is one of the most common causes of acute coronary syndrome (ACS) can occur over fibrous plaque or lipid-rich plaque (LRP) according to pathological reports. Whereas in plaque rupture (PR) the main cause of ACS, underlying plaque is basically LRP with thin fibrous cap. We aimed to investigate the clinical features and lipid profiles of PE with or without LRP in comparison to PR. Methods: A total of 165 statin-naïve patients with ACS who underwent percutaneous coronary intervention using optical coherence tomography and met the criteria for PR or PE were included. LRP was defined as a plaque with lipid having the maximal lipid arc (>180°). Culprit lesions were categorized into the PR, PE with/without LRP [PE(LRP), PE(Fibrous), respectively). Results: The prevalence of PR, PE(LRP), and PE(Fibrous) was 104 (63.0%), 42 (25.5%), and 19 (11.5%), respectively. Patients with PR and PE(LRP) had significantly higher peak creatine kinase (1338, 1733, 214 U/L, respectively, P<0.01) and more prevalence of ST-elevation myocardial infarction (71.2, 78.6, 21.1%, respectively, P<0.01) than PE(Fibrous). Overall, the levels of the various lipid profiles were mostly comparable between PE(Lipid) and PR but different in PE(Fibrous). The levels of small-dense low-density lipoprotein cholesterol was significantly greater in PR and PE(LRP) than in PE(Fibrous) (39.0, 36.6, 25.7 mg/dL, respectively, P=0.02). Conclusion: PE(LRP) had substantially different clinical features and lipid profiles compared to PE(Fibrous) showing some similarity to those of PR. Funding Acknowledgement: Type of funding sources: None.
- 1 October 2022
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 43 (Supplement)
Open AccessClinical features and lipid profiles of plaque erosion over lipid rich plaque versus fibrous plaque
Backgrounds and aims: Plaque erosion (PE) which is one of the most common causes of acute coronary syndrome (ACS) can occur over fibrous plaque or lipid-rich plaque (LRP) according to pathological reports. Whereas in plaque rupture (PR) the main cause of ACS, underlying plaque is basically LRP with thin fibrous cap. We aimed to investigate the clinical features and lipid profiles of PE with or without LRP in comparison to PR. Methods: A total of 165 statin-naïve patients with ACS who underwent percutaneous coronary intervention using optical coherence tomography and met the criteria for PR or PE were included. LRP was defined as a plaque with lipid having the maximal lipid arc (>180°). Culprit lesions were categorized into the PR, PE with/without LRP [PE(LRP), PE(Fibrous), respectively). Results: The prevalence of PR, PE(LRP), and PE(Fibrous) was 104 (63.0%), 42 (25.5%), and 19 (11.5%), respectively. Patients with PR and PE(LRP) had significantly higher peak creatine kinase (1338, 1733, 214 U/L, respectively, P<0.01) and more prevalence of ST-elevation myocardial infarction (71.2, 78.6, 21.1%, respectively, P<0.01) than PE(Fibrous). Overall, the levels of the various lipid profiles were mostly comparable between PE(Lipid) and PR but different in PE(Fibrous). The levels of small-dense low-density lipoprotein cholesterol was significantly greater in PR and PE(LRP) than in PE(Fibrous) (39.0, 36.6, 25.7 mg/dL, respectively, P=0.02). Conclusion: PE(LRP) had substantially different clinical features and lipid profiles compared to PE(Fibrous) showing some similarity to those of PR. Funding Acknowledgement: Type of funding sources: None.